Global Single-Use Bioprocessing Market is expected to foresee significant growth during the forecast period. North America to witness the highest growth
Global Single-Use Bioprocessing Market is expected to reach the market valuation of USD 14.47 billion by 2027 expanding at a reasonable CAGR of 17.40% during the forecast period (2021-2027) from USD 4.01 billion in 2020. Single-use systems are biopharmaceutical production (bioprocessing) products that are only used once and then discarded.
The various factors driving the Single-Use Bioprocessing market include the increasing popularity of disposables in biopharmaceutical manufacturing, rising instances of chronic diseases leading to the need for biological treatment, and developing life science research infrastructure drive the global single-use growth bioprocessing systems market. Furthermore, the increase in number of drug approvals is also anticipated to drive the market. Each year, the number of new medicinal items approved by the FDA fluctuates greatly: in 2016, just over 20 new pharmaceuticals were approved, while in 2018, almost 60 new products were approved.
For a detailed analysis of the market drivers in Single-Use Bioprocessing browse through - https://univdatos.com/report/single-use-bioprocessing-market
The COVID19 has resulted in a profound re-evaluation of the advantages and costs of single-use bioprocessing. The pandemic has been a devastating disease worldwide. Although an important number of young healthy people have been affected, elderly, comorbid and immunosuppressed patients have been especially compromised. The United States was one the world's most COVID-affected country. The number of daily reported deaths began to increase substantially in November 2020 and now the total number of cases is around 3.38 Cr. The North American government has been investing heavily in the development of COVID-19 vaccines, treatments, and diagnostic tests, which is expected to increase demand for single-use bioreactors and, as a result, overall market growth. The Canadian government committed CAD 275 million (EUR 179 million) in R&D funding for COVID-19 antivirals, diagnostics, vaccines, and clinical trials in March 2020. Furthermore, in April 2020, the United States government awarded Moderna Inc. USD 483 million for the development of a COVID-19 vaccine.
For a detailed analysis of the COVID-19 Impact on Single-Use Bioprocessing browse through - https://univdatos.com/report/single-use-bioprocessing-market
Several CMOs and biomanufacturers have moved their focus to the development of SARS-CoV-2 infection therapies employing disposable technology. Serum Institute used ABEC's Custom Single Run (CSR) technology in September 2020 to speed up large-scale, single-use manufacturing of roughly 1.0 billion doses of Novavax vaccine against COVID-19.
Based on product, the market is fragmented into media bags and containers, filtration assemblies, single-use bioreactors, disposable Mixers, and others. The media bags and containers segment dominated the market in 2020 and generated the total revenue of USD XX billion. It is anticipated to maintain its dominance during the forecast period owing to the increasing demand for biologics, affordability, and sustainability of single-use bioprocess technologies.
For a detailed analysis of the product in Single-Use Bioprocessing browse through - https://univdatos.com/report/single-use-bioprocessing-market
Based on end-user, the market is fragmented into life science R&D and biopharmaceutical manufacturers. The biopharmaceutical manufacturers segment dominated the market in 2020 and generated the total revenue of USD XX billion. It is anticipated to maintain its dominance during the forecast period. Moreover, the segment is also expected to witness highest CAGR during the analyzed period.
The various application wherein Single-Use Bioprocessing is utilized includes filtration, storage, cell culture, mixing, and purification. In 2020, filtration segment accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period.
Request for Sample of the report browse through - https://univdatos.com/request_form/form/482
Additionally, the report provides detailed initiatives that are being taken in the field of Single-Use Bioprocessing. The market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to the high R&D expenditure, the presence of largescale manufacturing units.
Thermo Fisher Scientific, Inc., Merck KGaA, Sartorius AG, Corning Incorporated, Pall Corporation, General Electric Company (GE Healthcare), Eppendorf AG, Rentschler Biopharma SE, Lonza, and Meissner Filtration Products, Inc., are some of the prominent players operating in the global Single-Use Bioprocessing market. Several M&A’s along with partnerships have been undertaken by these players to develop Single-Use Bioprocessing.
Global Single-Use Bioprocessing Market Segmentation
Market Insight, by Product
- Media Bags and Containers
- Filtration Assemblies
- Single-use Bioreactors
- Disposable Mixers
Market Insight, by End-User
- Life Science R&D
- Biopharmaceutical Manufacturers
Market Insight, by Application
- Cell Culture
Market Insight, by Region
- North America
- United States
- United Kingdom
- Rest of Europe
- Rest of Asia-Pacific
- Rest of World
Top Company Profiles
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Sartorius AG
- Corning Incorporated
- Pall Corporation
- General Electric Company (GE Healthcare)
- Eppendorf AG
- Rentschler Biopharma SE
- Meissner Filtration Products, Inc.